Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05399407
Other study ID # 2021PI178
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 9, 2023
Est. completion date January 9, 2025

Study information

Verified date October 2023
Source Central Hospital, Nancy, France
Contact Yacoubou OMOROU
Phone 0383859303
Email Y.OMOROU@chru-nancy.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study involves young adults from the PRALIMAP-INES trial and student volunteers from the University of Lorraine, who are overweight or obese. For young adults from the PRALIMAP-INES trial, the proposed research is a continuation of the PRALIMAP-CINeCO research (part 1). For students at the University of Lorraine, the proposed research is aimed at volunteer students who are overweight or obese, via the University of Lorraine's Student Health Service (SSE). Young adults and overweight or obese students not receiving medical care at the time of the inclusion visit (4th measurement time for PRALIMAP-INES participants and 1st time for others) will be offered the chance to take part in a randomized trial comparing the acceptability of health e-coaching versus referral to standard care. Experimental group: health e-coaching Control group: usual care system Primary objective : To determine the effectiveness of an e-health coaching intervention using new technologies that promotes changes in eating and physical activity behavior in overweight and obese young adults aged 20, an intervention targeting the development of autonomous self-regulation. Secondary objectives : 1. Determine the acceptability of health e-coaching: acceptability of new technologies (container), acceptability of personalized health e-coaching (content). 2. Determine the effectiveness of health e-coaching on the criteria of corpulence (BMI; body composition), changes in eating behaviors (TCA), emotion management skills and social interaction skills. 3. Evaluate the benefit of health e-coaching alone or combined with the previous intervention received in the PRALIMAP-INÈS trial on primary and secondary endpoints. 4. Evaluate and compare participation in a health promotion program over two life periods (adolescence and young adulthood) for young adults from the PRALIMAP-INÈS trial. 5. Evaluate the effectiveness of health e-coaching (reinforcement of autonomous self-regulation and changes in eating behaviors and physical activity practices/time spent sitting) according to the dose of intervention received by young adults (received-treatment analysis). 6. Determine the cost-efficiency and cost-utility ratios by means of a medico-economic evaluation based on the incremental cost of the e-coaching intervention in relation to the usual care offered by the health care system (ICER: Incremental Cost-Effectiveness Ratio).


Recruitment information / eligibility

Status Recruiting
Enrollment 384
Est. completion date January 9, 2025
Est. primary completion date January 9, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Among the young adults who agreed to participate in follow-up visit (T3) in the PRALIMAP-CINeCO trial (Part 1), the inclusion criteria for the inclusion criteria for the proposed research are as follows: - Person having received complete information on the organization of the research and not and who did not object to their participation and to the use of their data to participate and to use their data - Have agreed to complete the pre-test questionnaire prior to/at the follow-up visit (T3) - Have agreed to the anthropometric measurements without invasive intervention performed at the follow-up visit (Q3) - Have a BMI greater than 25kg/m² (Cole et al. 2000) or a percentage of body fat mass greater than or equal to 20% for men and greater than or equal to 33% for women, depending on age and greater than or equal to 33% for women and not receiving medical medical care for this situation - Agree to participate in the follow-up - Accepting the health e-coaching/orientation to routine care - Affiliated to a social security system or beneficiary of such a system - Reside in France Among the students who agreed to participate, through the Student Health Service of the University of Lorraine, the inclusion criteria for the proposed research are as follows: - Person having received complete information on the organization of the research and not and who did not object to their participation and to the use of their data to participate and to use their data - Have agreed to complete the pre-test questionnaire prior to/at the follow-up visit (T0) - Have agreed to the anthropometric measurements without invasive intervention performed at the follow-up visit (T0) - Have a BMI greater than 25kg/m² (Cole et al. 2000) or a percentage of body fat mass greater than or equal to 20% for men and greater than or equal to 33% for women, depending on age and greater than or equal to 33% for women and not receiving medical medical care for this situation - Agree to participate in the follow-up - Accepting the health e-coaching/orientation to routine care - Affiliated to a social security system or beneficiary of such a system - Reside in France - Be of legal age (18 years or older) - Be a student at the Université de Lorraine Exclusion Criteria: If the follow-up visit n°3 (T3) during the PRALIMAP-CINeCO trial (1st part) or the inclusion visit (T0 for University of Lorraine students), was completed, the non-inclusion criteria for the referral of young adults young adults (health e-coaching/current care) are as follows: - Do not feel the need for coaching - Be already being treated for overweight by a health professional specializing in the treatment of specialized in the treatment of overweight and obesity or a specialized specialized medical structure/service - Do not agree to participate in the continuation of PRALIMAP-CINeCO - Major person under a legal protection measure (guardianship, curatorship, safeguard of justice) - Persons deprived of liberty by a judicial or administrative decision administrative decision Persons under psychiatric care in accordance with Articles L. 3212-1 and L. 3213-1 of the Public Health Code

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Health e-coaching
Management of overweight / obesity

Locations

Country Name City State
France CHRU de Nancy Nancy

Sponsors (3)

Lead Sponsor Collaborator
Central Hospital, Nancy, France Cnam-ISTNA, University of Lorraine

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evolution of the corpulence determined from the body mass index [BMI] Body Mass Index (BMI) indicates the ratio between your weight and your height in meters squared (kg/m^2) Before and after intervention, an average of 1 year
Primary Change of the eating behaviors Diet, tobacco and alcohol consumption (food frequency questionnaire) Before and after intervention, an average of 1 year
Primary Change of the physical activity practices Physical activity and sedentary behaviour (GPAQ) Before and after intervention, an average of 1 year
Primary Change of the Self-regulatory skills Adaptation strategy (BriefCOPE) Before and after intervention, an average of 1 year
Primary Change of the Self Efficacy Diet TESQ-E (Self-Efficacy Diet Questionnaire) Before and after intervention, an average of 1 year
Secondary Level of satisfaction Satisfaction questionnaire Study completion, an average of 1 year
Secondary Change of the level of quality of Life Questionnaire EQ-5D-5L Before and after intervention, an average of 1 year
Secondary Change of the Knowledge on nutrition and physical activity Questionnaire of knowledge on nutrition and physical activity Before and after intervention, an average of 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A